PTC Therapeutics, Inc. (NASDAQ: PTCT) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT PTC THERAPEUTICS, INC.

PTC Therapeutics, Inc. (NASDAQ: PTCT)
Listen to this Section


$70.21
+1.5250 ( +2.22% ) 352.6K

PTC is a global biopharmaceutical company dedicated to the discovery, development, and commercialization of clinically differentiated medicines for children and adults living with rare disorders. PTC is advancing a robust and diversified pipeline of transformative medicines as part of its mission to provide access to best-in-class treatments for patients with unmet medical needs. The company's strategy is to leverage its scientific expertise and global commercial infrastructure to optimize value for patients and other stakeholders. To learn more about PTC, please visit www.ptcbio.com and follow on Facebook, X, and LinkedIn.

Market Data


Open $70.21
Previous Close $68.68
Volume 352.6K
Market Cap $5.70B
Day Range $68.63 - $71.52
52 Week Range $43.18 - $87.50
Shares Outstanding 82.95M
Change % +2.22%
Net Change ▲ 1.5250
Insider Ownership N/A
Exchange NASDAQ
SectorBasic Materials
IndustryPHARMACEUTICAL PREPARATIONS
IPO Year2013
CountryUnited States
UnderwriterIPO Intelligence Only

Insider Ownership Transactions

Total Amount Purchased: 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Filings


Form Type Description Pages Date
8-k 8K-related 14 Nov 04, 2025
10-q Quarterly Reports 97 Nov 04, 2025
4 Insider transactions 1 Oct 31, 2025
4 Insider transactions 1 Oct 09, 2025
4 Insider transactions 1 Oct 07, 2025
4 Insider transactions 1 Oct 07, 2025
4 Insider transactions 1 Oct 07, 2025
4 Insider transactions 1 Oct 07, 2025
4 Insider transactions 1 Sep 16, 2025
4 Insider transactions 1 Sep 15, 2025

Latest News


× Before browsing our site, please accept our cookies policy